New Delhi, India (CU)_ According to Dr Ram Vishwakarma, Chairman of the CSIR’s Covid Strategy Group, an Emergency Use Authorization for Merck’s Molnupiravir, which is an oral antiviral medication for the treatment of mild-to-moderate COVID-19, is anticipated to be approved for use within…
